Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Novavax (NVAX) vs. Competitors

10,192 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
NVAXNovavax$8.06$1.33B-17.4315.64%HoldUnlock the NVAX analyst price target with TipRanks PremiumNVAXUnlock the NVAX top-analyst price target with TipRanks Premium
VIRVir Biotechnology$9.58$1.64B-7.7270.16%Strong BuyUnlock the VIR analyst price target with TipRanks PremiumNVAX vs VIRUnlock the VIR top-analyst price target with TipRanks Premium
ORICOric Pharmaceuticals$7.52$779.47M-5.68-38.61%Strong BuyUnlock the ORIC analyst price target with TipRanks PremiumNVAX vs ORICUnlock the ORIC top-analyst price target with TipRanks Premium
ABCLAbCellera Biologics$11.12$3.63B-23.18201.36%Strong BuyUnlock the ABCL analyst price target with TipRanks PremiumNVAX vs ABCLUnlock the ABCL top-analyst price target with TipRanks Premium
SANASana Biotechnology$1.88$563.31M-3.57-52.88%Strong BuyUnlock the SANA analyst price target with TipRanks PremiumNVAX vs SANAUnlock the SANA top-analyst price target with TipRanks Premium

Performance Comparison

-100%0%100%200%300%400%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
NVAXNovavax8.061.4922.68%
VIRVir Biotechnology9.584.0874.18%
ORICOric Pharmaceuticals7.52-4.38-36.81%
ABCLAbCellera Biologics11.127.46203.83%
SANASana Biotechnology1.88-1.65-46.74%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts